Lv1
90 积分 2024-10-29 加入
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
23天前
已完结
Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
1个月前
已完结
Anticoagulation against portal vein thrombosis reduces mortality and liver cirrhosis‐related complications: A propensity score‐matched study
1个月前
已完结
Anticoagulants in cirrhosis: main concerns
2个月前
已完结
Anticoagulants in cirrhosis: main concerns
2个月前
已完结
Diagnostic Prediction of portal vein thrombosis in chronic cirrhosis patients using data-driven precision medicine model
4个月前
已完结
Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors
5个月前
已完结
Portal Vein Thrombosis in the Setting of Cirrhosis: Evaluation and Management Strategies
5个月前
已完结
Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study
7个月前
已完结
Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
7个月前
已完结
皖公网安备34019202002308
